Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
CRN-04894 by Crinetics Pharmaceuticals for Congenital Adrenal Hyperplasia (Adrenogenital Syndrome): Likelihood of Approval
CRN-04894 is under clinical development by Crinetics Pharmaceuticals and currently in Phase II for Congenital Adrenal Hyperplasia (Adrenogenital Syndrome). According...